Decade of Progress in Detecting Peptide Doping in Sports

Significant advances in liquid chromatography-mass spectrometry now enable detection of banned peptide substances including growth hormone releasing factors and gonadotropin-releasing hormone analogues in athlete samples.

Judák, Péter et al.·Journal of chromatography. B·2021·ModerateReview
RPEP-05475ReviewModerate2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate
Sample
N=N/A (methods review)
Participants
Review of anti-doping analytical methods for small peptides

What This Study Found

Significant progress in LC-MS-based doping control analysis of small peptides over the past decade, enabling reliable detection of growth hormone releasing factors and GnRH analogues among other banned peptide substances.

Key Numbers

10 years; LC-MS simplified; HRMS standard; metabolite detection; growing prohibited peptide list

How They Did This

Review of analytical methodology advances in sports doping control for small peptide detection, focusing on liquid chromatography-mass spectrometry approaches.

Why This Research Matters

Peptide doping is a growing problem in sports. Without reliable detection methods, athletes can gain unfair advantages using undetectable performance-enhancing peptides. These advances help maintain fair competition.

The Bigger Picture

The cat-and-mouse game between doping and detection drives analytical chemistry advances. As new performance-enhancing peptides emerge, detection methods must keep pace.

What This Study Doesn't Tell Us

Review of methods, not clinical outcomes. New designer peptides may still evade detection. Detection windows for some peptides remain short.

Questions This Raises

  • ?Can detection methods keep up with new designer peptides?
  • ?What are the current detection windows for popular peptide doping agents?
  • ?Should out-of-competition peptide testing frequency increase?

Trust & Context

Key Stat:
Decade of progress LC-MS analytical advances now enable reliable detection of small peptide doping substances that were previously undetectable
Evidence Grade:
Not applicable (analytical methodology review).
Study Age:
Published 2021. Doping detection continues advancing with new analytical technologies.
Original Title:
Doping control analysis of small peptides: A decade of progress.
Published In:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1173, 122551 (2021)
Database ID:
RPEP-05475

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Can peptide doping be detected?

Yes — modern LC-MS methods can detect many banned peptides in blood and urine. Detection has improved dramatically over the past decade, making it increasingly risky for athletes to use peptide-based performance enhancers.

What peptides are banned in sports?

Growth hormone releasing peptides (GHRPs), growth hormone releasing factors, gonadotropin-releasing hormone (GnRH) analogues, and other small peptides that enhance performance are banned by WADA. Detection methods now cover a broad range of these substances.

Read More on RethinkPeptides

Cite This Study

RPEP-05475·https://rethinkpeptides.com/research/RPEP-05475

APA

Judák, Péter; Esposito, Simone; Coppieters, Gilles; Van Eenoo, Peter; Deventer, Koen. (2021). Doping control analysis of small peptides: A decade of progress.. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1173, 122551. https://doi.org/10.1016/j.jchromb.2021.122551

MLA

Judák, Péter, et al. "Doping control analysis of small peptides: A decade of progress.." Journal of chromatography. B, 2021. https://doi.org/10.1016/j.jchromb.2021.122551

RethinkPeptides

RethinkPeptides Research Database. "Doping control analysis of small peptides: A decade of progr..." RPEP-05475. Retrieved from https://rethinkpeptides.com/research/judak-2021-doping-control-analysis-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.